Innova Biosciences Launches Range of Conjugated Antibodies
This new range includes antibodies conjugated to various enzymes, fluorescent dyes, and colloidal gold, for improved flexibility in experimental design.
Bioconjugation products and services provider, Innova Biosciences, has launched a range of conjugated antibodies, which leverages the company’s Lightning-Link and InnovaCoat bioconjugation technologies. This range includes antibodies conjugated to various enzymes, fluorescent dyes, and colloidal gold, for improved flexibility in experimental design.
The new range comprises 200 antibodies to nearly 30 different cardiac biomarkers, each available directly conjugated to 24 different enzymes, fluorescent dyes, or nanoparticles. Innova plans to expand the range into other key research areas in the near future.
In conjunction with the range, Innova has launched a new website that facilitates online ordering. The Antibody Conjugate Generator tool enables customers ordering from the new conjugated antibodies range to select any desired cardiac marker, antibody clone, and label. The website also provides resources and support materials.
More information about the new conjugated antibody range can be found at www.innovabiosciences.com/products/antibody-conjugates.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
